Episode 76

Targeting the Tumor Microenvironment in HCC

with Dr. Terence Gade and Dr. Michael Barraza

BackTable, LLC (Producer). (2020, August 10). Ep. 76 – Targeting the Tumor Microenvironment in HCC [Audio podcast]. Retrieved from https://www.backtable.com/podcasts

Interventional Radiologist Terence Gade from Penn Medicine, University of Pennsylvania Health System tells us about emerging research and therapies targeting the tumor microenvironment in Hepatocellular carcinoma (HCC).

Special thanks to our sponsor

Podcast Participants

Dr. Terence Gade is a practicing interventional radiologist with at the University of Pennsylvania.

Host Dr. Michael Barraza is a practicing interventional radiologist (and all around great guy) with Radiology Associates in Baton Rouge, LA.

TriSalus Infusion Systems

TriSalus Life Sciences is dedicated to improving patient outcomes in HCC and other highly intractable solid tumors. TriSalus Infusion Systems have the potential to deliver diagnostic, therapeutic, and immuno-stimulant agents directly into the tumor vascular, powered by their proprietary pressure-enabled delivery approach.

Show Notes

Hyperpolarized Metabolic Imaging Detects Latent Hepatocellular Carcinoma Domains Surviving Locoregional Therapy: https://pubmed.ncbi.nlm.nih.gov/31553806/

Association of Complete Radiologic and Pathologic Response following Locoregional Therapy before Liver Transplantation with Long-Term Outcomes of Hepatocellular Carcinoma: A Retrospective Study: https://pubmed.ncbi.nlm.nih.gov/30819472/

Learn more:

Transcript Preview

This transcript is not yet available.

Join The Discussion

Related Content

No related content.